Does Medicaid Cover Wegovy? Criteria, Copay, How to Appeal

Medicaid covers Wegovy for weight loss in 10 states as of November 2026: Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia and Wisconsin. Other approved uses, such as heart risk, can be covered elsewhere with prior authorization.

States covering weight loss: 10
Covered for type 2 diabetes: Every state
States covering in January 2026: 13
Prior authorization: Typical

Wegovy in short

How long it lasts in your body

Its half-life is about 1 week: after 7 d, half is gone, and after five half-lives (35 d) about 3% is left.

Weight loss in its main trial

In STEP 1 over 68 weeks, 14.9% of body weight was lost, compared with 2.4% on placebo.

Cost over time

Monthly prices in US dollars: the list price and self-pay offers, each taken from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

Does Medicaid cover Wegovy?

Wegovy and Medicaid
Medicine	Approved for	Medicaid covers it in
Wegovy	Weight loss, heart risk and MASH liver disease	10 states

Right now, states that cover GLP-1s for weight loss are: Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin.

Sources: TrumpRx, NovoCare, CMS, medicare.gov.

The published policy

States must cover diabetes GLP-1s: Yes
By state, weight loss coverage in October 2025: 16 states
By state, weight loss coverage in January 2026: 13 states
Prior authorization is needed
Changes in 2026:
- Michigan: Coverage is included (effective January 1, 2026), with tighter rules since January 2026
- During January 2026, it ended in Pennsylvania (effective January 1, 2026)
- Utah: Pilot ended June 2026 (effective June 30, 2026)
- For Wisconsin coverage, prior authorization applies (effective July 1, 2026)
- During July 2026, it ended in Massachusetts (effective July 3, 2026)
- During October 2026, it ended in Rhode Island (effective October 1, 2026)

Read KFF to see the policy itself.

Sources: KFF, michigan.gov, pa.gov, medicaid-documents.dhhs.utah.gov.

Prior authorization checklist

Your chart shows the weight diagnosis the plan asks for, or another approved Wegovy use for heart risk and MASH liver disease.
Prior authorization is needed
Records: your height and weight measurements, weight-related conditions, and the diet and activity program you already tried.
Your prescriber submits the prior authorization request, not you.

Source: KFF.

The appeal if you are denied

Denial reasons and fixes
Denial reason	What to send or ask
Criteria not met	Have your prescriber send the request again with your measured BMI and every weight-related condition listed in your chart.
The drug is not on the plan's list	Request a formulary exception, and learn which GLP-1 the plan prefers.

Get the denial notice from your Medicaid plan. It shows which rule was not met.
Your prescriber can resubmit the prior authorization by adding chart notes.
A state fair hearing is an option you can request if the plan still refuses.

State and plan variation

Medicaid GLP-1 coverage by state
State	For weight loss	For type 2 diabetes	Prior authorization
Alabama	Not covered	Covered	Not listed
Alaska	Not covered	Covered	Not listed
Arizona	Not covered	Covered	Not listed
Arkansas	Not covered	Covered	Not listed
California	Ended January 2026	Covered	Not listed
Colorado	Not covered	Covered	Not listed
Connecticut	Not covered	Covered	Not listed
Delaware	Covered with prior authorization	Covered	Required
District of Columbia	Not covered	Covered	Not listed
Florida	Not covered	Covered	Not listed
Georgia	Not covered	Covered	Not listed
Hawaii	Not covered	Covered	Not listed
Idaho	Not covered	Covered	Not listed
Illinois	Not covered	Covered	Not listed
Indiana	Joining BALANCE, start date not set	Covered	Not listed
Iowa	Not covered	Covered	Not listed
Kansas	Covered with prior authorization	Covered	Required
Kentucky	Not covered	Covered	Not listed
Louisiana	Not covered, law allows coverage from 2027	Covered	Not listed
Maine	Not covered	Covered	Not listed
Maryland	Not covered	Covered	Not listed
Massachusetts	Ended July 2026	Covered	Required
Michigan	Covered, tighter rules since January 2026	Covered	Required
Minnesota	Covered with prior authorization	Covered	Required
Mississippi	Covered	Covered	Not listed
Missouri	Covered with prior authorization	Covered	Required
Montana	Not covered	Covered	Not listed
Nebraska	Not covered	Covered	Not listed
Nevada	Not covered	Covered	Not listed
New Hampshire	Ended January 2026	Covered	Not listed
New Jersey	Not covered	Covered	Not listed
New Mexico	Not covered	Covered	Not listed
New York	Not covered	Covered	Not listed
North Carolina	Covered with prior authorization	Covered	Required
North Dakota	Not covered	Covered	Not listed
Ohio	Not covered	Covered	Not listed
Oklahoma	Not covered	Covered	Not listed
Oregon	Not covered	Covered	Not listed
Pennsylvania	Ended January 2026	Covered	Not listed
Rhode Island	Ended October 2026	Covered	Required
South Carolina	Ended January 2026	Covered	Not listed
South Dakota	Not covered	Covered	Not listed
Tennessee	Covered with prior authorization	Covered	Required
Texas	Not covered	Covered	Not listed
Utah	Pilot ended June 2026	Covered	Required
Vermont	Not covered	Covered	Not listed
Virginia	Covered with strict service authorization	Covered	Required
Washington	Not covered	Covered	Not listed
West Virginia	Not covered	Covered	Not listed
Wisconsin	Covered with prior authorization	Covered	Required
Wyoming	Not covered	Covered	Not listed

Sources: KFF, medicaidpublications.dhss.delaware.gov, events.in.gov, kdhe.ks.gov.

Other routes when coverage says no

Wegovy without coverage
Route	Who it is for	What you pay
NovoCare Pharmacy: Wegovy pill 1.5 mg	Self-pay, no insurance needed	$149 a month
TrumpRx listing (pill, starting)	Self-pay only, not with insurance	$149 a month

Prices checked November 2026. Each price links to its source page.